Phase II study of prolonged oral etoposide in combination with intravenous cisplatin in advanced non-small cell lung cancer
- 31 March 1995
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 12 (1-2) , 59-65
- https://doi.org/10.1016/0169-5002(94)00406-d
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity.Journal of Clinical Oncology, 1994
- Bioavailability of low-dose oral etoposide.Journal of Clinical Oncology, 1993
- Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.Journal of Clinical Oncology, 1992
- A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancerCancer, 1992
- Low-dose oral etoposide: a new role for an old drug?Journal of Clinical Oncology, 1990
- Chronic daily administration of oral etoposide in refractory lymphomaEuropean Journal of Cancer and Clinical Oncology, 1990
- The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observationCancer Chemotherapy and Pharmacology, 1989